ECHOMRI, LLC: public contracts won without a rival in United States

Updated 17 October 2026 · 2024-09-19 to 2026-09-16 · all of United States

ECHOMRI, LLC: public contracts won without a rival in United States: 3 uncontested awards; 75% of its awards; 1 without a competition; 2 single bid.

Assay record ASY-US-04JXSKQ1B5 · Cite as: Assay Systems, “ECHOMRI, LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/echomri-llc/

1
3uncontested awards
75%of its awards
1without a competition
2single bid

ECHOMRI, LLC won 3 of its 4 public contract awards in United States without a rival from 2024-09-19 to 2026-09-16, worth $322K: 1 without a competition and 2 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest National Institutes of Health with 3.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

National Institutes of Health3uncontested3awards$322Kvalue

National Institutes of Health gave ECHOMRI, LLC 3 awards: 1 without a competition, 2 after a competition with a single bid. First 2024-09-19, latest 2026-09-16.

Latest awards without a rival

DateBuyerHowValueStated reason
2026-09-16National Institutes of Health
75N98026P01676
No competition
NOT COMPETED UNDER SAP
$124KSAP NON-COMPETITION (FAR 13)
2026-06-11National Institutes of Health
75N98026P00748
Single bid
COMPETED UNDER SAP
$101K—
2024-09-19National Institutes of Health
75N95024P00656
Single bid
COMPETED UNDER SAP
$97.2K—

Every uncontested award in United States · All countries

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.